Respiratory stimulants: Nursing pharmacology

Last updated: January 27, 2022

Respiratory stimulants: Nursing pharmacology

Pharm

Pharm

Gastric mucosal protective agents: Nursing pharmacology
Histamine H2 antagonists: Nursing pharmacology
Treatment for Helicobacter pylori: Nursing pharmacology
Antiglaucoma medications: Nursing pharmacology
Geriatric considerations - Medications: Nursing
Substance use disorder - Medications and illicit drugs: Nursing
Medications to control airway secretions: Nursing pharmacology
Oral antidiabetic medications - Sulfonylureas and meglitinides: Nursing pharmacology
Oral antidiabetic medications - Biguanides and thiazolidinediones: Nursing pharmacology
Proton pump inhibitors (PPIs): Nursing pharmacology
Corticosteroids - Inhaled: Nursing pharmacology
Immunosuppressants for autoimmune diseases: Nursing pharmacology
Using an inhaler: Information for patients and families
Non-biologic disease-modifying antirheumatic drug (DMARD) therapy: Nursing pharmacology
Biologic agents: Nursing pharmacology
Medications for Alzheimer disease: Nursing pharmacology
Medications for growth hormone disorders: Nursing pharmacology
Glaucoma: Nursing process (ADPIE)
Geriatric considerations - Respiratory: Nursing
Antihyperlipidemics - Statins: Nursing pharmacology
Antihyperlipidemics - Bile acid sequestrants and cholesterol absorption inhibitors: Nursing pharmacology
Medication labels: Nursing pharmacology
Medications for thyroid disorders: Nursing pharmacology
Medication administration - Insulin: Nursing pharmacology
Antidepressants - SSRIs and SNRIs: Nursing pharmacology
Antidepressants - Tricyclic antidepressants (TCAs) and monoamine oxidase inhibitors (MAOIs): Nursing pharmacology
Insulin: Nursing pharmacology
Oral antidiabetic medications - Alpha-glucosidase inhibitors: Nursing pharmacology
Case study - Wound infection: Nursing
Medication administration - Heparin: Nursing pharmacology
Case study - Healthcare-associated infection (HAI): Nursing
Antibiotics - Fluoroquinolones: Nursing pharmacology
Stimulant medications for attention-deficit hyperactivity disorder (ADHD): Nursing pharmacology
Medication orders: Nursing pharmacology
Medication administration - Safety principles: Nursing pharmacology
Antiepileptics: Nursing pharmacology
Antibiotics - Carbapenems and monobactams: Nursing pharmacology
Cholinergic therapy (GU): Nursing pharmacology
Pharmacodynamics: Nursing pharmacology
Analgesics: Nursing pharmacology
Mood stabilizers: Nursing pharmacology
Antipsychotics: Nursing pharmacology
Anxiolytics and sedative-hypnotics: Nursing pharmacology
Antiemetics: Nursing pharmacology
Medications for acne vulgaris: Nursing pharmacology
Respiratory stimulants: Nursing pharmacology
Ergot alkaloids: Nursing pharmacology
Antibiotics - Penicillins: Nursing pharmacology
Antitumor antibiotics: Nursing pharmacology
Antibiotics - Macrolides: Nursing pharmacology
Antacids: Nursing pharmacology
Antihistamines: Nursing pharmacology
Laxatives: Nursing pharmacology
Prostaglandins: Nursing pharmacology
Antiarrhythmics: Nursing pharmacology
Thrombolytics: Nursing pharmacology
Antiprotozoals: Nursing pharmacology
Medications for migraines: Nursing pharmacology
Antispasmodics (GU): Nursing pharmacology
Iron preparations: Nursing pharmacology
Leukotriene modifiers: Nursing pharmacology
Nitrates: Nursing pharmacology
Beta-adrenergic blockers: Nursing pharmacology
Direct-acting vasodilators: Nursing pharmacology
Angiotensin-converting enzyme (ACE) inhibitors: Nursing pharmacology
Diuretics - Thiazide, thiazide-like, loop, and potassium-sparing diuretics: Nursing pharmacology
Cardiac glycosides: Nursing pharmacology
Antivirals for herpesviruses: Nursing pharmacology
Corticosteroids - Topical: Nursing pharmacology
Antibiotics - Metronidazole: Nursing pharmacology
Pancreatic enzyme replacements: Nursing pharmacology
Disease-modifying therapy for multiple sclerosis: Nursing pharmacology
Calcium-channel blockers: Nursing pharmacology
Anticoagulants - Warfarin: Nursing pharmacology
Anticoagulants - Heparin: Nursing pharmacology
Vaccines: Nursing pharmacology
Electrolyte balance - Overview: Nursing
Arterial blood gas (ABG) - Respiratory acidosis: Nursing
Antibiotics - Tetracyclines and glycylcyclines: Nursing pharmacology

Notes

RESPIRATORY STIMULANTS
DRUG NAME
doxapram, caffeine (Cafcit, NoDoz), theophylline (Elixophylline, Theo-24), aminophylline
CLASS
Respiratory stimulants
MECHANISM of ACTION
  • Stimulate respiratory center in the brainstem and medulla  → respiratory stimulation
  • Phosphodiesterase enzyme inhibitors → bronchodilation
INDICATIONS
  • Asthma
  • Respiratory depression
  • Apnea of prematurity
ROUTE(S) of ADMINISTRATION
  • PO
  • IV
SIDE EFFECTS
  • Muscle tremors
  • Agitation, anxiety, irritability, insomnia
  • Hypertension, heart palpitations, tachycardia, ECG abnormalities
  • Gastrointestinal disturbances: nausea, vomiting, diarrhea
  • Theophylline overdose: arrhythmias, seizures
  • Caffeine (high doses to premature infants): intracranial hemorrhage
CONTRAINDICATIONS and CAUTIONS
  • Arteriosclerosis, cardiovascular disease, hypertension
  •  Pregnancy and breastfeeding
  • History of seizures
  • Hepatic or renal disease
  • Theophylline: drug interactions with beta blockers, phenytoin, beta adrenergic agonists, antidepressants, cimetidine, ciprofloxacin, tobacco smoke, and marijuana
NURSING CONSIDERATIONS
Assessment and monitoring 
Assessment
  • Vital signs, especially respiratory rate; SpO2, lung sounds
  • Laboratory test results: renal and hepatic function

Monitoring
  • Vital signs 
  • Serum drug concentration levels; not to exceed 20 mcg/mL
  • Side effects 
  • Evaluate therapeutic response: improved airflow and decreased respiratory effort

Client education
  • Purpose of medication: help them to breathe easier
  • Take medication in the morning, with or without food
    • Avoid taking at bedtime
  • Avoid smoking, alcohol, and dietary sources of caffeine, like coffee, tea, soda, and chocolate
  • Side effects to report
    • Nausea, irritability, anxiety, tachycardia, palpitations, insomnia, nausea
      • If side effects are persistent or severe
    • Symptoms of toxicity: dizziness, lightheadedness, fatigue, weakness, shortness of breath
Author: Antonia Syrnioti, MD
Illustrator: Robyn Hughes, MScBMC

Transcript

Watch video only

Respiratory stimulants are a group of medications that can be administered to clients with asthma, chronic obstructive pulmonary disease or COPD for short, or respiratory depression; as well as to treat apnea of prematurity.

Respiratory stimulants include doxapram, which is administered intravenously, as well as certain phosphodiesterase enzyme inhibitors, also known as methylxanthines, such as caffeine, theophylline, and aminophylline, which are most often taken orally, but they can also be given intravenously.

Once administered, these medications primarily work on the brainstem and medulla by stimulating the respiratory center, and thus act as respiratory stimulants.

In addition, methylxanthines can also act on the lungs by inhibiting the phosphodiesterase enzyme, and ultimately cause bronchodilation.

Side effects commonly caused by respiratory stimulants include muscle tremors, agitation, anxiety, irritability, and insomnia. Clients might also experience gastrointestinal disturbances like nausea, vomiting, and diarrhea.

These drugs may also cause hypertension, heart palpitations, tachycardia, and ECG abnormalities.

In addition, theophylline has a very narrow therapeutic window, meaning it's very easy to overdose, and can cause arrhythmias or seizures.

Finally, administering high doses of caffeine to premature infants can lead to intracranial hemorrhage.

As far as contraindications go, respiratory stimulants are contraindicated in clients with severe arteriosclerosis, symptomatic cardiovascular disease, and moderate to severe hypertension.

Respiratory stimulants should also be avoided in clients with a history of seizures, as well as hepatic or renal disease.

Additional precautions should be taken during pregnancy and breastfeeding. Regarding interactions, theophylline and phenytoin should not be used together, as they decrease each other’s effects.

Finally, theophylline should not be combined with beta blockers, beta adrenergic agonists, antidepressants, H2 blockers like cimetidine, or certain antibiotics like ciprofloxacin, as well as tobacco smoke and marijuana, since these medications can increase the levels of theophylline and result in toxicity. Due to the dangerous potential side effects, theophylline is now rarely used.

Now, when caring for a client who is prescribed a respiratory stimulant like theophylline to improve their respiratory function, first perform a baseline assessment, including vital signs, especially respiratory rate, as well as SpO2, and lung sounds. Then, review your client’s recent laboratory test results, including renal and hepatic function.

Key Takeaways

Respiratory stimulants are medications that are used to increase or improve breathing in individuals who have respiratory disorders or conditions. These medications can be used to treat a variety of conditions, including asthma, chronic obstructive pulmonary disease, or respiratory depression; as well as to treat apnea of prematurity.

Respiratory stimulants primarily work on the brainstem and medulla by stimulating the respiratory center, or act on the lungs by causing bronchodilation. Respiratory stimulants include drugs like doxapram, caffeine, theophylline, and aminophylline. Some common side effects can include muscle tremors, agitation, anxiety, irritability, and insomnia.

Sources

  1. "Karch’s Focus on Nursing Pharmacology. 9th edition. ISBN: 978-1-975180-40-9" LWW (2023)
  2. "Pharmacology: A Patient-Centered Nursing Process Approach. 9th edition. ISBN: 978-0-323-39916-6 " Elsevier Canada (2020)
  3. "Mosby’s 2023 Nursing Drug Reference. 36th edition. ISBN: 978-0-323-93072-7" Mosby (2022)
  4. "Saunders Comprehensive Review for the NCLEX-RN. 9th Edition. ISBN: 978-0-323-79530-2" Saunders (2022)
  5. "Countering opioid-induced respiratory depression by non-opioids that are respiratory stimulants. 9:F1000 Faculty Rev-91" F1000Res (2020 Feb 7)
  6. "Asthma and Corticosteroid Responses in Childhood and Adult Asthma. 40(1):163-177" Clin Chest Med (2019)
  7. "2019 Year in Review: Aerosol Therapy. 65(5):705-712" Respir Care (2020)